Počet záznamů: 1
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis
- 1.Peters, D. E., Norris, L. D., Tenora, L., Šnajdr, I., Ponti, A. K., Zhu, X., Sakamoto, S., Veeravalli, V., Pradhan, M., Alt, J., Thomas, A. G., Majer, P., Rais, R., McDonald, C., Slusher, B. S. A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis. Science Translational Medicine. 2023, 15(708), eabn7491. ISSN 1946-6234. E-ISSN 1946-6242. Dostupné z: doi: 10.1126/scitranslmed.abn7491.
Počet záznamů: 1